New approaches in the treatment of bacterial infections
- 25 July 2000
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 4 (4) , 433-439
- https://doi.org/10.1016/s1367-5931(00)00106-x
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- First Drug for Penicillin-Resistant Community-Acquired PneumoniaPublished by American Medical Association (AMA) ,2000
- Gatifloxacin Activity against Quinolone-Resistant Gyrase: Allele-Specific Enhancement of Bacteriostatic and Bactericidal Activities by the C-8-Methoxy GroupAntimicrobial Agents and Chemotherapy, 1999
- Quinupristin/dalfopristin, a new addition to the antimicrobial arsenalThe Lancet, 1999
- Effects of Genes Encoding Resistance to Streptogramins A and B on the Activity of Quinupristin-Dalfopristin against Enterococcus faeciumAntimicrobial Agents and Chemotherapy, 1999
- Phenotypic Distinction in Enterococcus faecium and Enterococcus faecalis Strains between Susceptibility and Resistance to Growth-Enhancing AntibioticsAntimicrobial Agents and Chemotherapy, 1999
- Distribution of Genes Encoding Resistance to Macrolides, Lincosamides, and Streptogramins among StaphylococciAntimicrobial Agents and Chemotherapy, 1999
- A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new ‘respiratory quinolones’Journal of Antimicrobial Chemotherapy, 1999
- Quinupristin/DalfopristinDrugs, 1999
- Antimicrobial Activity of Quinupristin-Dalfopristin (RP 59500, Synercid®) Tested against Over 28,000 Recent Clinical Isolates from 200 Medical Centers in the United States and CanadaDiagnostic Microbiology and Infectious Disease, 1998
- Killing of Staphylococcus aureus by C-8-Methoxy FluoroquinolonesAntimicrobial Agents and Chemotherapy, 1998